Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase

Neurology. 2007 Aug 14;69(7):699-700. doi: 10.1212/01.wnl.0000267884.39468.7a.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Administration, Oral
  • Cholinesterase Inhibitors / administration & dosage*
  • Humans
  • Myasthenia Gravis / drug therapy*
  • Myasthenia Gravis / enzymology*
  • Oligonucleotides, Antisense / administration & dosage*

Substances

  • Cholinesterase Inhibitors
  • Oligonucleotides, Antisense
  • Acetylcholinesterase